IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection

J Immunol. 2001 Dec 1;167(11):6453-61. doi: 10.4049/jimmunol.167.11.6453.

Abstract

Several reports have indicated that cell lineages apart from NK and T cells can also express IFN-gamma. However, the biological relevance of this finding is uncertain. We show in this study that bone marrow-derived macrophages (BMMs) express IFN-gamma at the mRNA and protein level early after infection with Chlamydia pneumoniae. Increased IFN-gamma mRNA accumulation by infected BMMs is early, transient, and requires both bacterial and host protein synthesis. The induction of IFN-gamma mRNA levels is independent of IL-12 and was dramatically enhanced in IL-10(-/-) BMMs. Such IL-10(-/-) BMMs contained less bacteria than the wild-type controls, whereas IFN-gammaR(-/-) BMMs showed increased C. pneumoniae load. Inducible NO synthase (iNOS) also participates in the control of bacterial load, as shown by the enhanced numbers of C. pneumoniae in iNOS(-/-) BMMs. However, the increased accumulation of iNOS mRNA and NO in C. pneumoniae-infected BMMs depended on the presence of IFN-alphabeta, but was independent of IFN-gamma. Interestingly, IFN-alphabeta are also required for increased IFN-gamma mRNA accumulation in C. pneumoniae-infected BMMs. Accordingly, IFN-alphabetaR(-/-) BMMs showed higher levels of C. pneumoniae than wild-type BMMs. Our findings unravel an autocrine/paracrine macrophage activation pathway by showing an IFN-alphabeta-dependent IFN-gamma and iNOS induction in response to infection, which protects macrophages against intracellular bacterial growth.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Bone Marrow Cells / enzymology
  • Bone Marrow Cells / immunology*
  • Bone Marrow Cells / metabolism
  • Bone Marrow Cells / microbiology*
  • Cells, Cultured
  • Chlamydophila pneumoniae / growth & development*
  • Chlamydophila pneumoniae / immunology*
  • Growth Inhibitors / metabolism
  • Growth Inhibitors / physiology
  • Interferon Type I / physiology*
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism*
  • Interleukin-10 / physiology
  • Interleukin-12 / physiology
  • Intracellular Fluid / enzymology
  • Intracellular Fluid / immunology
  • Intracellular Fluid / microbiology
  • Macrophages / enzymology
  • Macrophages / immunology*
  • Macrophages / metabolism
  • Macrophages / microbiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Nitric Oxide Synthase / biosynthesis
  • Nitric Oxide Synthase Type II
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics

Substances

  • Anti-Bacterial Agents
  • Growth Inhibitors
  • Interferon Type I
  • RNA, Messenger
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse